Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...

Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia (VT), have been published in Circulation.

Atrioventricular nodal reentrant tachycardia (AVNRT) is one of the most commonly encountered arrhythmias worldwide, and catheter ablation remains its treatment of choice. Ablation techniques, ...

Berlin, Germany – 8 April 2024: The first randomised trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients ...

Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication ...

Please provide your email address to receive an email when new articles are posted on . “Cryoconvergent” hybrid ablation for atrial fibrillation may significantly reduce risk for recurrent AF and AF ...

Thermedical®, a developer of advanced thermal-ablation technologies, today announced that the first patient has been treated in a pivotal clinical study evaluating its Saline Enhanced Radiofrequency ...

Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.

Now, Imricor Medical Systems (ASX:IMR) can add its imprint to the Mending Broken Hearts Club, after Dutch surgeons used its cardiac ablation device in a groundbreaking procedure. Imricor has developed ...

Direct oral anticoagulants (DOACs) bested aspirin for cerebrovascular prevention after left ventricular (LV) arrhythmia ablation, the STROKE-VT trial showed. The anticoagulants eliminated stroke ...